Qualigen Therapeutics

-$0.0104 (-1.99%) As of 1:36 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell QLGN and other ETFs, options, and stocks.

About QLGN

Qualigen Therapeutics, Inc. is a biotechnology company focused on developing therapeutics for the treatment of cancer and infectious diseases. The company's cancer therapeutics pipeline includes ALAN (AS1411-GNP), RAS-F3 and STARS.

CEO
Michael S. Poirier
Employees
46
Headquarters
Carlsbad, California
Founded
2004

QLGN Key Statistics

Market cap
18.11M
Price-Earnings ratio
—
Dividend yield
—
Average volume
243.35K
High today
$0.5418
Low today
$0.5113
Open price
$0.5418
Volume
8.12K
52 Week high
$3.12
52 Week low
$0.45

QLGN Earnings

-$3.17
-$1.98
-$0.78
$0.41
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
— per share
Actual
-$0.12 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure